October 29, 2025 20:00 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE…
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base…
Executive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug…
DUISBURG, Germany, Sept. 19, 2025 /PRNewswire/ -- Factor2 Energy, a German (Duisburg) company with a novel approach to geothermal energy, today…
NEW DELHI, Sept. 2, 2025 /PRNewswire/ -- HarperCollins India is delighted to present a new novel by Chetan Bhagat, an irresistible…
ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to…
Series is Based on New York Times Best Selling Novel and Expands the Popular "True the Game" Franchise Beyond the…
August 21, 2025 01:30 ET | Source: NICOX SA Press Release Nicox Announces Positive Results from the NCX 470 Phase…
August 13, 2025 13:41 ET | Source: Striim, Inc. PALO ALTO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- With fast…
AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™ (Serplulimab), the first PD-1 inhibitor globally approved for…